Theodore R. Schroeder, Chief Executive Officer at Nabriva Therapeutics plc (NBRV), bought 100,000 shares at $1.13 ($113K) on 2021-09-14, disclosed to the SEC on 2021-09-15.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Clearly above the average filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $1.13 | 50,000 | $56K | 50.0% |
| 2 | $1.13 | 50,000 | $57K | 50.0% |
| Total | $1.13 avg | 100,000 | $113K | 100% |
| Filing → |
| CADX | BUY | 2011-05-17 | $120K | — | Filing → |
| CADX | SELL | 2010-10-04 | $418K | — | Filing → |
| CADX | SELL | 2010-07-01 | $350K | — | Filing → |